EN
The relationship between chronic viral hepatitis and erectile dysfunction in male patients more than 65 years old
Abstract
Objective: Erectile dysfunction is defined as the incomplete failure of penile erection for satisfying sexual intercourse. Its incidence is quite high in male patients over 65 years of age. Many diseases, such as Diabetes Mellitus, obesity, and psychiatric diseases, affect erectile dysfunction. In our study, we aimed to show the relationship between chronic viral hepatitis and erectile dysfunction in male patients over 65 years of age.
Method: A single-center retrospective study. Sixty-five male patients over 65 years old, 35 chronic viral hepatitis, 30 healthy controls were included in our study. Patients with comorbidities facilitating erectile dysfunction such as diabetes mellitus, obesity, and psychiatric disease were excluded from our study.
Results: Erectile dysfunction was found in 49 of the 65 patients included in our study. There was no significant difference between HDL, Triglyceride, AST, ALT, GGT, LDH, Total Protein, and Albumin levels in the control group with hepatitis (p> 0.05). On the other hand, age and erectile dysfunction were found statistically significantly higher in the group with hepatitis (p <0.001, p = 0.002, respectively). IIEF, Total cholesterol and LDL were statistically significantly higher in the Control group (p <0.001, p = 0.01 and p = 0.02, respectively).
Conclusions: The incidence of erectile dysfunction was higher in male patients over 65 years of age with chronic viral hepatitis compared to the control group. There was a significant relationship between erectile dysfunction and chronic viral hepatitis and advanced age.
Keywords
Kaynakça
- 1- Svatikova, A., & Kopecky, S. L. (2020). Why and How Cardiovascular Screening Should Be Implemented in Sexual Medicine Practice: Erectile Dysfunction and Cardiovascular Disease. The Journal of Sexual Medicine, 17(6), 1045-1048.
- 2- Levy, J. (2002). Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. The British Journal of Diabetes & Vascular Disease, 2(4), 278-280.
- 3- Kendirci, M., Asci, R., Yaman, Ö., Cayan, S., Orhan, I., Usta, M. F., ... & Kadioglu, A. (2014). Prevalence of male pelvic dysfunction: results from the Turkish society of andrology male sexual health study group. Andrology, 2(2), 219-224.
- 4- Shamloul, R., & Ghanem, H. (2013). Erectile dysfunction. The Lancet, 381(9861), 153-165.
- 5- Cazzaniga, W., Capogrosso, P., Montorsi, F., Salonia, A., URI, I. O. S. R., & Boeri, L. (2020). Erectile Dysfunction. Urologic Principles and Practice, 159.
- 6- Rusiecki, L., Zdrojowy, R., Gebala, J., Rabijewski, M., Sobieszczańska, M., Smoliński, R., ... & Kałka, D. (2020). Sexual health in Polish elderly men with coronary artery disease: importance, expectations, and reality. Asian Journal of Andrology.
- 7- Konstantinovsky, A., Tamir, S., Katz, G., Tzischinsky, O., Kuchersky, N., Blum, N., & Blum, A. (2019). Erectile Dysfunction, Sleep Disorders, and Endothelial Function. The Israel Medical Association journal: IMAJ, 21(6), 408-411.
- 8- Wan, Z. H., Zhang, Y. J., Chen, L., Guo, Y. L., Li, G. H., Wu, D., & Wang, Y. (2019). G protein-coupled receptor kinase 2 inhibition improves erectile function through amelioration of endothelial dysfunction and oxidative stress in a rat model of type 2 diabetes. Asian journal of andrology, 21(1), 74.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yayımlanma Tarihi
31 Aralık 2020
Gönderilme Tarihi
3 Aralık 2020
Kabul Tarihi
17 Aralık 2020
Yayımlandığı Sayı
Yıl 2020 Cilt: 42 Sayı: 4